Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a Letter of Support (LoS ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error during the treatment process.

About Biora Therapeutics Biora Therapeutics is a clinical-stage biotech company developing two smart pill-based therapeutics platforms: the NaviCap™ platform for colon-targeted treatment of IBD, ...

Takeda Canada Inc. ("Takeda") announces new data highlighting the impact Inflammatory Bowel Disease (IBD) has on Canadians. The data reveals insights into how the disease affects daily life, the ...

Werewolf Therapeutics, Inc. (the“Company” or“Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to ...

The study identifies links between gut microbiota, genetic variants in IBD, and mental health disorders, offering insights ...

Chaos in Austria's Kirchberg ob der Donau as a man shot the mayor and a hunter there. A manhunt is currently underway for the ...

According to a new comprehensive report from The Insight Partners, the Global Gastrointestinal Drugs Market is observing ...

1 People with inflammatory bowel disease are characterised by hypercoagulation, hypofibrinolysis, and platelet activation, 2,4 but the underlying mechanism is still unclear. Intestinal dysbiosis ...

Frenchie, the Franco-English singer-songwriter formerly known as the Naked Eye, has announced her self-titled debut album. Produced by jazz guitarist Femi Temowo (SAULT, Amy... South London’s Moreish ...